UnitedHealth Group (UNH) to Release Earnings on Tuesday

UnitedHealth Group (NYSE:UNH - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Tuesday, July 29th. Analysts expect the company to announce earnings of $5.16 per share and revenue of $111.75 billion for the quarter.

UnitedHealth Group Stock Up 1.1%

UnitedHealth Group stock traded up $3.06 during trading on Tuesday, reaching $285.20. The stock had a trading volume of 14,233,925 shares, compared to its average volume of 7,873,392. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group has a 52-week low of $248.88 and a 52-week high of $630.73. The business has a 50 day moving average price of $304.47 and a 200 day moving average price of $432.39. The stock has a market cap of $258.72 billion, a PE ratio of 11.94, a P/E/G ratio of 1.38 and a beta of 0.45.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.10%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Wells Fargo & Company reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Morgan Stanley dropped their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, HSBC reissued a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $394.43.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

Institutional Trading of UnitedHealth Group

A hedge fund recently raised its stake in UnitedHealth Group stock. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 137.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,019 shares of the healthcare conglomerate's stock after buying an additional 2,324 shares during the quarter. Revolve Wealth Partners LLC's holdings in UnitedHealth Group were worth $2,033,000 as of its most recent filing with the Securities and Exchange Commission. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.